U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s also facing additional government scrutiny

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more.

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,